Health behaviour
Healthy lifestyle and multimorbidity risk
Open access · cc by · source: Europe PMC
Healthier lifestyle scores tracked lower CVD and diabetes risk and lower multimorbidity transitions.
Study at a glance
- Design
- Cohort — EPIC multinational prospective cohort; healthy lifestyle index
- N
- N=291778 · 64% women; median follow-up 11.0 years
- Population
- EPIC adults free of cancer, CVD, and T2D at baseline across European centres
- Outcome
- Incident cancer, CVD, T2D, and subsequent multimorbidity by lifestyle index
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
Over median 11.0 years, 3244 people developed multimorbidity. Higher HLI was inversely associated with CVD (HR 0.77 per 3 units) and T2D (HR 0.67), less so with cancer (HR 0.89).
Methodology
A multinational prospective cohort related a healthy lifestyle index and component behaviours to cancer, CVD, type 2 diabetes, and subsequent multimorbidity.
Limitations
Observational lifestyle scores remain open to residual confounding; this is not a randomised lifestyle trial.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
A web programme can raise daily activity and short-term weight and HbA1c markers in older adults.
In older adults, a web-based activity programme increased ankle-measured daily activity (~46% vs ~12% in controls) and was associated with greater short-term weight and HbA1c improvements than control.
Scope note — different design — observational lifestyle index, not an activity RCT
Limits the claim's scope: a different population, assay, or outcome.
A child-care nutrition and activity trial shifted zBMI slightly, with design caveats.
In a child-care nutrition/activity RCT, intervention versus control differed in mean zBMI change (coeff about −0.14), with center-level randomisation and socioeconomic imbalances noted as caution flags.
Scope note — different design — adult observational multimorbidity, not child zBMI RCT
Limits the claim's scope: a different population, assay, or outcome.
Healthier lifestyle scores associate with lower CVD and diabetes incidence in cohorts.
In a multinational prospective cohort, a higher healthy lifestyle index was inversely associated with incident CVD (HR about 0.77 per 3 units) and type 2 diabetes (HR about 0.67), and more weakly with cancer (HR about 0.89).
Evidence for the claim as stated.
After type 2 diabetes, healthier behaviours still associate with fewer microvascular complications.
Among UK Biobank adults with type 2 diabetes, more low-risk lifestyle behaviours were associated with lower later microvascular complication rates—extending lifestyle scoring from incidence to complications-after-diagnosis.
Scope note — different outcome — incident multimorbidity/T2D, not microvascular events
Limits the claim's scope: a different population, assay, or outcome.
Digital tools show mixed proximal effects — logging more is not the same as preventing disease.
Digital tools show mixed proximal endpoints: a step-log app was associated with higher odds of continued daily logging versus matched controls, while a small uncontrolled smoking EMI reported 20% biochemically confirmed abstinence at 12 weeks.
Scope note — different endpoint — hard disease outcomes, not app engagement
Limits the claim's scope: a different population, assay, or outcome.
Randomised activity/diet programmes, observational lifestyle indices, and digital pilots measure different endpoints (minutes walked, zBMI, incident disease, logging, abstinence). Treating them as one efficacy number manufactures agreement that the designs do not support.
Evidence for the claim as stated.
Short-term behaviour change during an intervention (walking minutes, logging) is not the same claim as durable post-stimulus effects or long-horizon disease associations.
Evidence for the claim as stated.
Among people with type 2 diabetes, healthier lifestyles associate with fewer later microvascular problems.
Among UK Biobank adults with type 2 diabetes and no baseline vascular complications, a higher count of low-risk lifestyle behaviours at baseline was associated with lower subsequent hospital/death-recorded microvascular events (composite HR about 0.54 for 4–5 vs 0–1 behaviours in fully adjusted models; about 18% lower composite risk per additional low-risk behaviour).
Scope note — different outcome — incident T2D/multimorbidity, not complications after diagnosis
Limits the claim's scope: a different population, assay, or outcome.
Across countries, healthier lifestyle scores associate with lower new diabetes and CVD rates.
In a multinational prospective cohort, a higher healthy lifestyle index was inversely associated with incident type 2 diabetes (HR about 0.67 per 3 index units) and CVD (HR about 0.77), and more weakly with cancer (HR about 0.89); 3,244 people developed multimorbidity over a median 11.0 years.
Evidence for the claim as stated.
Lifestyle scores summarise habits; they are not the same evidence as a randomised lifestyle trial.
In Nurses’ Health Study I and II, longer duration of rotating night-shift work was associated with higher incident type 2 diabetes risk (age-adjusted HR about 1.64 in NHS I and 2.50 in NHS II for ≥20 years vs never).
Scope note — different exposure — combined lifestyle index, not shift work
Limits the claim's scope: a different population, assay, or outcome.
Lifestyle scores for incident diabetes/multimorbidity and lifestyle scores for microvascular complications after diabetes diagnosis answer different clinical questions. An association in people who already have T2D does not validate—or refute—primary-prevention estimates, and vice versa.
Evidence for the claim as stated.
Rotating night-shift duration is an occupational exposure schedule; healthy lifestyle indices combine voluntary behaviours. Both relate to diabetes risk in these cohorts, but they are not competing estimates of the same lever—treating them as a disagreement forces a false choice.
Evidence for the claim as stated.
A multinational prospective cohort linked a healthy lifestyle index to later disease over a median 11.0 years, during which 3,244 people developed multimorbidity. Higher HLI was inversely associated with CVD (HR 0.77 per 3 units) and type 2 diabetes (HR 0.67), and more weakly with cancer (HR 0.89). Observational lifestyle scores remain open to residual confounding.
Evidence for the claim as stated.
Follow-up of thousands of event-free adults is a different design from a 74-person telemedicine case series, even if both get filed as cohorts. The HLI, diet-depression, smoking-CVD and Rotterdam papers estimate rates or attributable fractions over years. The WeChat paper describes outcomes after care already delivered, with no control group, so it cannot show that monitoring caused recovery.
Evidence for the claim as stated.
Protective lifestyle HRs and harmful drug HRs are not interchangeable clinical instructions. Diet-quality HRs around 0.74–0.78 and HLI HRs of 0.67–0.77 do not prove that prescribing a diet would prevent depression or diabetes, while extra falls on named antidepressants may mark who is prescribed them rather than a pure drug effect. Norwegian cancer-survival SES gradients even became non-significant after stage and smoking were in the model.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Randomised activity/diet programmes, observational lifestyle indices, and digital pilots measure different endpoints (minutes walked, zBMI, incident disease, logging, abstinence). Treating them as one efficacy number manufactures agreement that the designs do not support.
- Supports · Web program increased older adults’ measured activity in a trial
- Supports · Child-care diet/activity RCT and zBMI
- Supports · Does a step-log app keep people tracking activity?
- Supports · Smart-T smoking EMI app
- Supports · Facebook team walking RCT
Short-term behaviour change during an intervention (walking minutes, logging) is not the same claim as durable post-stimulus effects or long-horizon disease associations.
- Supports · Facebook team walking RCT
Lifestyle scores for incident diabetes/multimorbidity and lifestyle scores for microvascular complications after diabetes diagnosis answer different clinical questions. An association in people who already have T2D does not validate—or refute—primary-prevention estimates, and vice versa.
Rotating night-shift duration is an occupational exposure schedule; healthy lifestyle indices combine voluntary behaviours. Both relate to diabetes risk in these cohorts, but they are not competing estimates of the same lever—treating them as a disagreement forces a false choice.
- Supports · Night shifts and type 2 diabetes risk
Follow-up of thousands of event-free adults is a different design from a 74-person telemedicine case series, even if both get filed as cohorts. The HLI, diet-depression, smoking-CVD and Rotterdam papers estimate rates or attributable fractions over years. The WeChat paper describes outcomes after care already delivered, with no control group, so it cannot show that monitoring caused recovery.
Protective lifestyle HRs and harmful drug HRs are not interchangeable clinical instructions. Diet-quality HRs around 0.74–0.78 and HLI HRs of 0.67–0.77 do not prove that prescribing a diet would prevent depression or diabetes, while extra falls on named antidepressants may mark who is prescribed them rather than a pure drug effect. Norwegian cancer-survival SES gradients even became non-significant after stage and smoking were in the model.
- Supports · Diet quality and depression risk
- Supports · Antidepressant adverse events cohort
- Supports · Does socioeconomic status change cancer survival?
History
When this study was placed
Dated entries from the concept change log — when this paper was added or removed as support, challenge, or qualifier on a claim.
Removed as supporting evidence on Health Behaviour
In older adults, a web-based activity programme increased ankle-measured daily activity (~46% vs ~12% in controls) and was associated with greater short-term weight and HbA1c improvements than control.
Placed as a scope qualifier on Health Behaviour
In older adults, a web-based activity programme increased ankle-measured daily activity (~46% vs ~12% in controls) and was associated with greater short-term weight and HbA1c improvements than control.
Placed as a scope qualifier on Health Behaviour
In a child-care nutrition/activity RCT, intervention versus control differed in mean zBMI change (coeff about −0.14), with center-level randomisation and socioeconomic imbalances noted as caution flags.
Placed as supporting evidence on Health Behaviour
In a multinational prospective cohort, a higher healthy lifestyle index was inversely associated with incident CVD (HR about 0.77 per 3 units) and type 2 diabetes (HR about 0.67), and more weakly with cancer (HR about 0.89).
Placed as a scope qualifier on Health Behaviour
Among UK Biobank adults with type 2 diabetes, more low-risk lifestyle behaviours were associated with lower later microvascular complication rates—extending lifestyle scoring from incidence to complications-after-diagnosis.
Placed as a scope qualifier on Health Behaviour
Digital tools show mixed proximal endpoints: a step-log app was associated with higher odds of continued daily logging versus matched controls, while a small uncontrolled smoking EMI reported 20% biochemically confirmed abstinence at 12 weeks.
Placed as supporting evidence on Health Behaviour
Short-term behaviour change during an intervention (walking minutes, logging) is not the same claim as durable post-stimulus effects or long-horizon disease associations.
Related papers in this topic
Same topic cluster — not a recommendation engine.